BSE: 526853
To view real time prices Login to your account
Already an existing customer? - Login Now!
BSE Click here to view BSE data
Live Chart
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
Div yield:

Fundamental analysis


0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Not Applicable
MARKET CAP (Micro Cap Stock)Rs Cr
PE (TTM) 0.00
PE Ratio-4.14
Price to Book Value2.27
EV to EBIT32.36
EV to EBITDA12.76
EV to Capital Employed1.11
EV to Sales0.83
PEG Ratio0.00
Dividend YieldNA
ROCE (Latest)3.44%
ROE (Latest)-54.68%
NameDec 22Sep 22
Promoters (Change:-0.00) 30.01%30.01%
FIIs (Change:-0.00) 0.04%0.04%
Mutual Funds (Change:0.00) 0%0%
Insurance Companies (Change:0.00) 0%0%
Other DIIs (Change:0.00) 0%0%
Non Institution (Change:-0.00) 69.94%69.94%

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000


Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

BI News

Frequently Asked Questions

What is the Share price of BILCARE LTD. (BI)?

BILCARE LTD. (BI) share price as of February 4, 2023, on BSE is Rs 61.75 (BSE).

Can I buy BILCARE LTD. (BI) shares?

Yes, You can buy BILCARE LTD. (BI) shares by opening a Demat account with Angel One.

How do I buy BILCARE LTD. (BI) from Angel One?

BILCARE LTD. (BI) share can be brought through the following modes:
  1. Direct investment: You can buy BILCARE LTD. (BI) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to BILCARE LTD. (BI) shares.

In which sector do BILCARE LTD. (BI) belong?

BILCARE LTD. (BI) belongs to Packaging .

About BI

Today's live share price for BILCARE LTD. is NSE: N/A, BSE: ₹ 61.75 with a current market capitalization of .

Bilcare Ltd is a research-based organization primarily engaged in manufacturing specialty pharmaceutical packaging barrier films. The company provides pharmaceutical research services, clinical services and packaging systems and material. The company's key products include packaging films, aluminum foils, wrap systems, cold formed blisters, closures and containers, and paper composites. They also offer research services, including preformulation studies, formulation development, analytical research, stability studies, packaging audit and packaging development and design. Bilcare Ltd was incorporated on July 1987 as Bhandari Paper Products Pvt Ltd and converted into a public limited company on Oct. 27, 1994. The name of the company was changed to BI Ltd in the year 2001 and further the name was changed to Bilcare Ltd on October 1, 2003. The company's plant at Rajgurunagar in Pune is one of its kinds in Asia and the eighth plant of its kind in the world. During the year 1997-98, company completed the project of Paper Tube Plant at Patalganga in Maharashtra. During the year 1999-2000, German Investment and Development company namely DEG - Deutsche Investitions - Und Entwicklungsgesellschaft MBH has subscribed to 21% of the share capital of PT Bhandari Mishindo, a subsidiary of the company. During the year 2002-03, the company introduced seven new unique products for the pharma sector namely Nova, Patina, Ultra, Excel, Super Zing and Venus. During the year 2003-04, the company hived off their Biltube Division in order to focus their core business of manufacture of pharma packaging and research. Also, PT Bhandari Mishindo, a subsidiary company in Indonesia which was formed as an integral part of the Biltube Division was ceased to be a subsidiary of the company. Also, the company promoted Bilcare Singapore Pte Ltd as a wholly owned subsidiary of the company during the year. In July 2005, Bilcare Singapore Pte Ltd, a wholly owned subsidiary of the company acquired pharma research and clinical services business in USA. Thus Bilcare Inc became a subsidiary of the company. In October 2005, the company unveiled their clinical services facility in Pune. This facility will support the pharma companies in packaging and distribution of their clinical supplies and integrate their global clinical trial requirements efficiently. In September 2006, the company acquired DHP Ltd, a UK-based Clinical Trials Services provider through Bilcare (UK) Ltd, a wholly owned subsidiary of Bilcare Singapore Pte Ltd. In May 2007, Bilcare Research announced the launch of the Bilcare Research Academy in partnership with Association of Clinical Research Professionals (ACRP), US. The academy shall open 25 centers in India and other parts of Asia by 2010. In January 2008, Bilcare Singapore has bought 100% of Singular ID, the provider of integrated high technology enterprise brand security system, for a consideration of Singapore Dollar 19.58 million. Bilcare Singapore is a wholly owned subsidiary of the company. In July 2008, Bilcare Ltd and USA based MeadWestvaco Corp jointly acquired the pharmaceutical packaging Company International Labs of St. Petersburg, Florida, USA.

Read more

Enjoy Zero Brokerage on Equity Delivery

Join our 1 Cr+ happy customers